Overweight Clinical Trial
Official title:
Influence of a Food Supplement on the Gut Microbiome in Healthy Obese Women
Before and after study in obese women 25-35 years old, BMI 30-35, taking Strath® Kräuterhefe Original (liquid), Herbal Yeast Food Supplement for three weeks. At the beginning and after three weeks of the study a stool sample is provided. These samples are analysed with 16S rRNA analysis down to species level.The results are interpreted with the PICRUSt classification and Alpha Diversity Analysis and compared to internationally accepted data bases.
Intervention: Variation of the gut microbiome via intake of an herbal yeast preparation.
Participants: healthy obese women between 25 and 35 years. Intervention to be studied: Intake
of Strath® Kräuterhefe Original (liquid), Herbal Yeast Food Supplement over 3 weeks, stool
analysis.
Sequence and duration of all study periods: 7 weeks per proband.
Week -4 - -2: Pre-Phase Hand out study information First check of inclusion/exclusion
criteria
Week -2: Initiation-Phase Signed "Informed Consent" Second check of inclusion/exclusion
criteria Complete assessment Part I, II (see 8.2) Start assessment Part IV (see 8.2)
Week 0: Intervention-Phase Implementation of food supplement Complete assessment Part III
(see 8.2) Third check of inclusion/exclusion criteria
Week 3: Evaluation-Phase Complete assessment Part II, III and IV Fourth check of
inclusion/exclusion criteria Compliance control
5.2 Methods of minimising bias (ICH/E6 6.4.3; AGEK 4.3; SPIRIT #16, 17) ICH: A description of
the measures taken to minimize/avoid bias, including: Randomization, Blinding.
Homogenous sample selection. 5.2.1 Randomisation Not applicable
5.2.2 Blinding procedures Not applicable
5.2.3 Other methods of minimising bias The investigators are going to do a semi-quantitative
screening to determine a participant's nutritional habits.
Questions about their nutritional habits asked in the screening (via questionnaire);
1. Does the participant have a particular or alternative lifestyle (e.g. vegan, vegetarian,
only eating raw fruits and vegetables, etc.)?
- if yes → excluded
2. Does the participant control your nutrition in any form (food diary, app, counting
calories, etc.)?
- if yes → excluded
3. Does the participant consciously eat food to strengthen your immune system or do you
take additional supplements to influence your intestinal bacteria (e.g. pro- and/or
prebiotic food like Actimel, Activia, etc.)?
- if daily or weekly → excluded
4. Does the participant exercise regularly? If yes, how often? - if 3h/week or more →
excluded
5. On how many days per week does the participant eat meat or meat products?
- if less then twice and more than five times peer week → excluded
6. On how many days per week does the participant eat fish?
- if less or more than twice per week / 5 times per month → excluded
7. On how many days per week does the participant eat salad, vegetables or vegetable juice
(not counting potatoes)?
- if less than 5 days per week → excluded
8. On how many days per week does the participant eat fruits or drink fruit juices
approximately?
- if less than 5 days per week → excluded
9. On how many days per week does the participant drink or eat milk or milk products
approximately? - if less than 4 days per week → excluded
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Terminated |
NCT03299881 -
Safety and Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS)-Assisted Weight Loss
|
N/A | |
| Completed |
NCT02805478 -
Fat-Associated Cardiovascular Organ Dysfunction
|
||
| Active, not recruiting |
NCT02558920 -
Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity
|
||
| Completed |
NCT03759743 -
Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject
|
N/A | |
| Completed |
NCT03610958 -
Safety and Performance Evaluation of the Epitomee Device for Enhancing Satiety and Weight Loss.
|
N/A | |
| Completed |
NCT03678766 -
CHARGE: Controlling Hunger and ReGulating Eating
|
N/A | |
| Completed |
NCT04430465 -
Effects of Wholegrains on Children's Health (KORN)
|
N/A | |
| Completed |
NCT04117802 -
Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome
|
N/A | |
| Completed |
NCT05376865 -
Effects of Vitamin D Supplementation on Obesity, Inflammatory and Metabolic Markers
|
N/A | |
| Completed |
NCT03625427 -
Effect of Palmitoleic Acid on C-reactive Protein
|
N/A | |
| Active, not recruiting |
NCT03435445 -
Online Platform for Healthy Weight Loss (POEmaS)
|
N/A | |
| Enrolling by invitation |
NCT05576116 -
Combined Bariatric Surgery and Pancreas After Kidney Transplantation for Type II Diabetics
|
N/A | |
| Recruiting |
NCT05249465 -
Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention
|
N/A | |
| Active, not recruiting |
NCT06023095 -
A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities
|
Phase 1 | |
| Completed |
NCT03648892 -
Brain Dopamine Function in Human Obesity
|
Early Phase 1 | |
| Not yet recruiting |
NCT05751993 -
Piloting a Reinforcement Learning Tool for Individually Tailoring Just-in-time Adaptive Interventions
|
N/A | |
| Recruiting |
NCT02887950 -
Resistant Starch, Epigallocatechin Gallate and Chlorogenic Acid for Body Weight Loss in Menopause
|
N/A | |
| Completed |
NCT02829229 -
Community-based Obesity Treatment in African American Women After Childbirth
|
N/A | |
| Terminated |
NCT02796144 -
MEtformin and Lorcaserin for WeighT Loss in Schizophrenia
|
Phase 4 |